Chemoinformaics analysis of N-methyl- (CAS) Nmethylformamide Methylformamide
Molecular Weight | 59.068 | nRot | 1 |
Heavy Atom Molecular Weight | 54.028 | nRig | 1 |
Exact Molecular Weight | 59.0371 | nRing | 0 |
Solubility: LogS | 0.966 | nHRing | 0 |
Solubility: LogP | -0.836 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 9 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 4 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 5 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 2 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 8.57596 |
nHD | 1 | BPOL | 6.45403 |
QED | 0.4 |
Synth | 3.194 |
Natural Product Likeliness | 0.554 |
NR-PPAR-gamma | 0.002 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.008 |
HIA | 0.009 |
CACO-2 | -4.694 |
MDCK | 0.000668531 |
BBB | 0.796 |
PPB | 0.106701 |
VDSS | 1.571 |
FU | 0.899232 |
CYP1A2-inh | 0.138 |
CYP1A2-sub | 0.391 |
CYP2c19-inh | 0.058 |
CYP2c19-sub | 0.499 |
CYP2c9-inh | 0.014 |
CYP2c9-sub | 0.738 |
CYP2d6-inh | 0.005 |
CYP2d6-sub | 0.774 |
CYP3a4-inh | 0.006 |
CYP3a4-sub | 0.134 |
CL | 4.999 |
T12 | 0.841 |
hERG | 0.009 |
Ames | 0.059 |
ROA | 0.014 |
SkinSen | 0.273 |
Carcinogencity | 0.021 |
EI | 0.584 |
Respiratory | 0.176 |
NR-Aromatase | 0.004 |
Antiviral | No |
Prediction | 0.909667 |